V
DXCM icon

Veritable’s DexCom DXCM Stock Holding History

Veritable’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,632
Closed -$852K – 235
2023
Q2 		$852K Buy
6,632
+681
+11% +$82.4K 0.01% 402
2023
Q1 		$691K Buy
5,951
+554
+10% +$62K 0.01% 454
2022
Q4 		$611K Buy
5,397
+569
+12% +$62.5K 0.01% 471
2022
Q3 		$389K Buy
4,828
+201
+4% +$17K 0.01% 565
2022
Q2 		$345K Sell
4,627
-929
-17% -$84.8K 0.01% 634
2022
Q1 		$711K Buy
5,556
+280
+5% +$30.6K 0.01% 471
2021
Q4 		$708K Buy
5,276
+1,108
+27% +$159K 0.01% 476
2021
Q3 		$570K Buy
4,168
+52
+1% +$6.56K 0.01% 510
2021
Q2 		$439K Buy
4,116
+760
+23% +$73K 0.01% 575
2021
Q1 		$302K Sell
3,356
-104
-3% -$9.76K 0.01% 658
2020
Q4 		$320K Sell
3,460
-804
-19% -$71.8K 0.01% 609
2020
Q3 		$439K Buy
4,264
+244
+6% +$25.5K 0.01% 485
2020
Q2 		$407K Buy
4,020
+376
+10% +$33.6K 0.01% 514
2020
Q1 		$245K Sell
3,644
-304
-8% -$18.9K 0.01% 617
2019
Q4 		$216K Buy
+3,948
New +$187K ﹤0.01% 766

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Veritable's DXCM Position: Q3 2023 in Review

Veritable sold out of DexCom (DXCM) in Q3 2023, closing a stake of 6,632 shares — an estimated $852K sold.

Veritable first reported a position in DXCM in Q4 2019 and held it in 15 quarters. The position peaked at $852K in Q2 2023. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Veritable reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Veritable sold 6,632 DexCom shares in Q3 2023, an estimated $852K.
  • Veritable first reported a position in DexCom in Q4 2019 and held it in 15 quarters.
  • Veritable's DexCom position peaked at $852K in Q2 2023.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.